We are live on ! Find out more
DC

Defender Capital Portfolio holdings

AUM $308M
1-Year Est. Return 4.52%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
+4.52%
3 Year Est. Return
+83.48%
5 Year Est. Return
+78.82%
10 Year Est. Return
–
AUM
$291M
AUM Growth
+$4.5M
Cap. Flow
+$4.29M
Cap. Flow %
1.48%
Top 10 Hldgs %
91.27%
Holding
41
New
2
Increased
12
Reduced
13
Closed
4

Top Buys

1
VGSH icon
Vanguard Short-Term Treasury ETF
VGSH
+$5.82M
2
STAA icon
STAAR Surgical
STAA
+$1.57M
3
FTV icon
Fortive
FTV
+$1.47M
4
PFE icon
Pfizer
PFE
+$698K
5
TDY icon
Teledyne Technologies
TDY
+$666K

Top Sells

1
MNST icon
Monster Beverage
MNST
+$2.27M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.25M
3
AXON
Axon Enterprise
AXON
+$951K
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$605K
5
ENOV icon
Enovis
ENOV
+$512K

Sector Composition

1 Healthcare 25.07%
2 Technology 19.02%
3 Financials 15.39%
4 Consumer Staples 9.24%
5 Industrials 5.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VGSH icon
1
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$69.5M 23.9%
1,204,145
+99,975
+9% +$5.82M
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.06T
$44.2M 15.21%
129,764
-3,819
-3% -$1.25M
DHR icon
3
Danaher
DHR
$144B
$34.6M 11.89%
162,524
+1,560
+1% +$330K
FTV icon
4
Fortive
FTV
$18.8B
$30M 10.32%
532,655
+29,064
+6% +$1.47M
STAA icon
5
STAAR Surgical
STAA
$1.3B
$27.2M 9.35%
517,352
+25,855
+5% +$1.57M
MNST icon
6
Monster Beverage
MNST
$94.7B
$17.4M 5.98%
302,667
-39,913
-12% -$2.27M
TDY icon
7
Teledyne Technologies
TDY
$29.4B
$14.7M 5.05%
35,707
+1,615
+5% +$666K
AXON
8
Axon Enterprise
AXON
$41.6B
$11.4M 3.93%
58,557
-4,590
-7% -$951K
COST icon
9
Costco
COST
$415B
$9.22M 3.17%
17,130
+505
+3% +$256K
LCTX icon
10
Lineage Cell Therapeutics
LCTX
$294M
$7.2M 2.48%
5,109,710
-26,375
-0.5% -$36.4K
PLTR icon
11
Palantir
PLTR
$321B
$5.18M 1.78%
337,540
+13,210
+4% +$150K
INTC icon
12
Intel
INTC
$484B
$2.73M 0.94%
81,715
-3,100
-4% -$97.3K
BE icon
13
Bloom Energy
BE
$62.1B
$2.61M 0.9%
159,300
+6,500
+4% +$105K
ESAB icon
14
ESAB
ESAB
$5.56B
$2.47M 0.85%
37,075
-948
-2% -$57.5K
ANIP icon
15
ANI Pharmaceuticals
ANIP
$1.79B
$1.29M 0.44%
24,000
– –
MSFT icon
16
Microsoft
MSFT
$2.93T
$1.12M 0.38%
3,286
-93
-3% -$29.1K
AAPL icon
17
Apple
AAPL
$4.88T
$980K 0.34%
5,053
-2,129
-30% -$371K
CVX icon
18
Chevron
CVX
$372B
$944K 0.32%
6,005
-995
-14% -$160K
LFCR icon
19
Lifecore Biomedical
LFCR
$180M
$836K 0.29%
86,450
– –
AMZN icon
20
Amazon
AMZN
$2.66T
$665K 0.23%
5,100
+140
+3% +$16K
PFE icon
21
Pfizer
PFE
$142B
$658K 0.23%
+17,935
New +$698K
IWM icon
22
iShares Russell 2000 ETF
IWM
$82.2B
$581K 0.2%
3,100
– –
INFL icon
23
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.47B
$556K 0.19%
18,200
– –
IMDX
24
Insight Molecular Diagnostics
IMDX
$154M
$535K 0.18%
116,397
-1,775
-2% -$8.94K
IVV icon
25
iShares Core S&P 500 ETF
IVV
$883B
$525K 0.18%
1,179
– –
1
2

Similar funds

PC
Pecaut & Co Sioux City, Iowa $308M AUM 15.9% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
FUBT
First United Bank & Trust Oakland, Maryland $308M AUM 19.08% 1-Year Est. Return
AC
Alfreton Capital Radlett, Hertfordshire, United Kingdom $308M AUM 10.23% 1-Year Est. Return
EWM
Elite Wealth Management Kirkland, Washington $308M AUM 30.88% 1-Year Est. Return
ICP
Islander Capital Partners San Francisco, California $308M AUM
ACM
Argyle Capital Management Center Valley, Pennsylvania $308M AUM 24.01% 1-Year Est. Return
GE
General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return

Defender Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Defender Capital held 41 positions worth $291M, up 1.6% from $286M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Defender Capital's Q2 2023 filing shows 2 new, 12 increased, 13 reduced and 4 closed positions. Its largest new stake was Pfizer: 17,935 shares worth $658K. The largest sale was Monster Beverage, an estimated $2.27M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Defender Capital's largest Q2 2023 buy was Pfizer: 17,935 shares worth $658K.
  • Defender Capital added most to Vanguard Short-Term Treasury ETF in Q2 2023, an estimated $5.82M increase.
  • Defender Capital's biggest Q2 2023 reduction was Monster Beverage, cutting an estimated $2.27M.
  • Defender Capital fully exited Alphabet (Google) Class A in Q2 2023, selling an estimated $605K.
  • Defender Capital's ten largest holdings make up 91% of its $291M portfolio in Q2 2023.
  • Defender Capital opened 2 new positions and closed 4 in Q2 2023.
  • Defender Capital's portfolio value rose 1.6% quarter-over-quarter to $291M.

Based on Defender Capital's 13F filing for Q2 2023, filed 18 Jul 2023.